These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A mathematical model of the rat nephron: glucose transport. Weinstein AM Am J Physiol Renal Physiol; 2015 May; 308(10):F1098-118. PubMed ID: 25694480 [TBL] [Abstract][Full Text] [Related]
8. SGLT2 Inhibitors and the Diabetic Kidney. Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829 [TBL] [Abstract][Full Text] [Related]
9. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats. Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891 [TBL] [Abstract][Full Text] [Related]
11. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end? Castellino P; Shohat J; DeFronzo RA Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280 [TBL] [Abstract][Full Text] [Related]
13. Adaptive changes in GFR, tubular morphology, and transport in subtotal nephrectomized kidneys: modeling and analysis. Layton AT; Edwards A; Vallon V Am J Physiol Renal Physiol; 2017 Aug; 313(2):F199-F209. PubMed ID: 28331059 [TBL] [Abstract][Full Text] [Related]
14. Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models. Tauber P; Sinha F; Berger RS; Gronwald W; Dettmer K; Kuhn M; Trum M; Maier LS; Wagner S; Schweda F Front Pharmacol; 2021; 12():761855. PubMed ID: 34992532 [TBL] [Abstract][Full Text] [Related]
15. Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review. Kalra S; Singh V; Nagrale D Adv Ther; 2016 Sep; 33(9):1502-18. PubMed ID: 27423646 [TBL] [Abstract][Full Text] [Related]
16. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Vervoort G; Veldman B; Berden JH; Smits P; Wetzels JF Eur J Clin Invest; 2005 May; 35(5):330-6. PubMed ID: 15860045 [TBL] [Abstract][Full Text] [Related]
17. Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy. Škrtić M; Cherney DZ Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):96-103. PubMed ID: 25470017 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes. Lei Y; Devarapu SK; Motrapu M; Cohen CD; Lindenmeyer MT; Moll S; Kumar SV; Anders HJ Front Immunol; 2019; 10():1223. PubMed ID: 31191559 [TBL] [Abstract][Full Text] [Related]
19. Automated Image Analyses of Glomerular Hypertrophy in a Mouse Model of Diabetic Nephropathy. Østergaard MV; Sembach FE; Skytte JL; Roostalu U; Secher T; Overgaard A; Fink LN; Vrang N; Jelsing J; Hecksher-Sørensen J Kidney360; 2020 Jun; 1(6):469-479. PubMed ID: 35368599 [TBL] [Abstract][Full Text] [Related]
20. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide. Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]